Detalles de la búsqueda
1.
Clinical factors and biomarkers predict outcome in patients with immune-mediated thrombotic thrombocytopenic purpura.
Haematologica
; 104(1): 166-175, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30171022
2.
Transfusion of Platelets Loaded With Recombinant ADAMTS13 (A Disintegrin and Metalloprotease With Thrombospondin Type 1 Repeats-13) Is Efficacious for Inhibiting Arterial Thrombosis Associated With Thrombotic Thrombocytopenic Purpura.
Arterioscler Thromb Vasc Biol
; 38(11): 2731-2743, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30354235
3.
A machine learning approach to predict mortality due to immune-mediated thrombotic thrombocytopenic purpura.
Res Pract Thromb Haemost
; 8(3): 102388, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38651093
4.
Plasma levels of S100A8/A9, histone/DNA complexes, and cell-free DNA predict adverse outcomes of immune thrombotic thrombocytopenic purpura.
J Thromb Haemost
; 19(2): 370-379, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33188723
5.
Longitudinal assessments of plasma ADAMTS13 biomarkers predict recurrence of immune thrombotic thrombocytopenic purpura.
Blood Adv
; 3(24): 4177-4186, 2019 12 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31856267
6.
A descriptive analysis of fatal outcomes in immune thrombotic thrombocytopenic purpura in the USTMA TTP Registry.
Blood Adv
; 8(3): 620-623, 2024 02 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38100454
7.
Therapeutic efficacy of the platelet glycoprotein Ib antagonist anfibatide in murine models of thrombotic thrombocytopenic purpura.
Blood Adv
; 1: 75-83, 2016 Nov 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28480350
Resultados
1 -
7
de 7
1
Próxima >
>>